The announcement is expected within the next 48 hours, but the timing could move.

An Israeli woman receives the coronavirus vaccine (photo credit: AVSHALOM SASSONI/FLASH90)
An Israeli woman receives the coronavirus vaccine
(photo credit: AVSHALOM SASSONI/FLASH90)

The Food and Drug Administration is slated to amend the emergency use authorizations for the Pfizer and the Moderna Covid-19 vaccines Thursday to allow immunocompromised people to get a third dose, NBC News reported.

The announcement is expected within the next 48 hours, but the timing could move, according to multiple sources.

The Biden administration is anticipated to put out a Covid-19 vaccine booster strategy for all vaccinated Americans in September.

On July 12, Israel began to offer a booster shot for people with a severely weakened immune system. Preliminary results from research conducted by the Rabin Medical Center-Beilinson Campus in Petah Tikva and Clalit Health Services has shown that administering a third coronavirus vaccine shot to immunocompromised patients significantly increases their ability to produce antibodies.

The FDA move would be the first authorization of an additional dose in the US.

As reported by The Jerusalem Post